JUNE 15, 2007
VOLUME 4 NO. 11

PATIENTS & PRACTICE

Cancer scandal puts path standards
under the scope

Confidence shattered after widespread faulty ER/PR
testing revealed in Newfoundland


One woman's ER/PR nightmare

Five years ago Verna Doucette of Port au Port Peninsula, Newfoundland, was diagnosed with having a small, three-to-five centimetre cancerous tumour in her right breast. Today she's at the centre of the health scandal that's rocking the Rock.

Nearly five years ago to the day, Ms Doucette, who was 47 at the time, had an open biopsy which led to her being diagnosed with an infiltrating ductal carcinoma. Tests to determine if the tumour was receptive to hormone stimulation showed negative estrogen receptors and progesterone receptors less than 5%.

Almost four years later, Ms Doucette received a letter from her oncologist telling her that her samples had been retested and the results were very different indeed. Estrogen receptors were now showing 60% and progesterone, 30%.

If this had been known earlier, Ms Doucette would have been offered tamoxifen, but instead she went through a six-cycle course of chemotherapy. The chemo brought on chest infections and reactivated an old tuberculosis infection.

Ms Doucette is the representative plaintiff named in the class action lawsuit filed by lawyer Ches Crosbie on behalf of the women.

Shockwaves from the breast cancer testing scandal that's rocked Newfoundland are shaking up diagnostic standards in the province.

In late May Danny Williams' government was forced to admit that more than 300 flawed estrogen/progestin receptor (ER/PR) tests in the province had resulted in inaccurate diagnoses and treatment of breast cancer patients. At least 176 of the women are now dead.

The government is under fire because the admission came only after the affected women launched a class action lawsuit even though the government knew about the problem for the last two years. Newfoundland has now initiated a judicial inquiry to determine what happened.

In the spirit of a new culture of transparency, the health authority at the centre of the scandal, Eastern Health, quickly announced the unrelated suspension of a radiologist under review for 6,000 questionable reports on some 3,500 patients. The government provoked the ire of the reviewing physicians when health minister Ross Wiseman ordered them to complete their review in just two weeks.

The two shocking cases have those in health circles asking what happened — and what's next?

CHILLING DISCOVERY
The problem came to light, says Dr Kara Laing, Eastern Health's cancer program clinical chief, when the situation of one patient who had a negative ER/PR test made her doctors question whether she might be positive. The test was reordered.

Meanwhile Eastern Health had installed a new automatic Ventana system in its immunohistochemistry lab. Before, testing was done using a more complex semi-automatic system. The second test with the new equipment confirmed the doctors' suspicions. Based on this, Eastern Health decided to do further retesting going back to 1997. Negative samples were sent to Mount Sinai Hospital in Toronto for an independent review.

A court analysis signed by Dr Charles Hutton, a former provincial forensic pathologist and currently a deputy medical examiner and forensic consultant, suggests the number of false results could be as high as 366; 176 of these patients have since died. Although the cause of their deaths isn't known, 105 retests from these patients' tissue samples also confirmed false results.

PATHOLOGY UNDER FIRE
No one knows yet how this happened, but the case has highlighted two big problems on the Rock: suboptimal testing standards and pathologist shortages.

Was Newfoundland using outmoded equipment? Not necessarily, says Dr Jagdish Butany, president of the Canadian Association of Pathologists (CAP) and a pathologist at the Toronto General Hospital. "Ten years ago, everyone was using semi-automatic systems," he says.

Dr Nash Denic, Eastern Health's chief pathologist for its laboratory program, says the health authority has since established a centre of excellence for breast cancer pathology with a goal to improve standards. Eastern Health will also continue sending some samples to Toronto for quality control.

"What we should learn from this Newfoundland case is that we need quality assurance standards," says Dr Butany. "Ontario has standards in place already. Why not set up a national system?" He says CAP has struck a committee to look at standards nationwide and he hopes to get recommendations in place in the not-too-distant future.

PATH DEARTH
"Newfoundland even now has the worst proportion of work to pathologists and the worst salaries in the country," says Dr Butany. "They get people from everywhere who come and stay for two years then move on. They never have a full complement of staff so there's no continuity. They're barely coping."

The Newfoundland and Labrador Medical Association (NLMA) has been after the government about the pathologist shortage for years. An NLMA spokesperson emphasizes it's yet to be determined whether this shortage was a factor in the false ER/PR test results.

"The shortages shouldn't affect the quality of care," notes Dr Butany.

Health Minister Wiseman admits there's been a 50% turnover in pathologists since 1997. He says he hopes the province's new enhanced compensation package for pathologists will boost recruitment and retention.

 

 

back to top of page

 

 

 

 
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T.